Literature DB >> 25119153

Neurocutaneous melanosis is associated with tethered spinal cord.

Ashley G Tian1, Kimberly A Foster, Regina I Jakacki, Miguel Reyes-Múgica, Stephanie Greene.   

Abstract

PURPOSE: Neurocutaneous melanosis (NCM) is a rare congenital disorder occurring in children born with multiple or large congenital melanocytic nevi (CMN) in association with melanocytic deposits in the leptomeninges. Multiple associations between NCM and other syndromes or neurologic abnormalities have been reported. Of note, there exists a possible association between NCM and tethered cord (TC).
METHODS: We retrospectively reviewed charts and films of all patients with the diagnosis of NCM at the Children's Hospital of Pittsburgh (CHP) from August 2002 to present.
RESULTS: Five children met the criteria for NCM at our institution over a 12-year period. Apart from the melanocytic deposits, one or more additional spinal abnormalities were identified in all children. Three children had radiographic evidence of a low-lying conus medullaris, two of which also demonstrated lipomatous infiltration of the filum terminale, consistent with a tethered cord (TC).
CONCLUSIONS: Clinical features of NCM include dermatologic and neurologic manifestations. To date, this is the first series to note an association between NCM and TC. While nearly all recent series of NCM patients advocate early MRI of the neuroaxis, we recommend screening imaging of the spine on children with possible NCM regardless of the locations of CMN.

Entities:  

Mesh:

Year:  2014        PMID: 25119153     DOI: 10.1007/s00381-014-2526-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  35 in total

Review 1.  Spinal cord traction, vascular compromise, hypoxia, and metabolic derangements in the pathophysiology of tethered cord syndrome.

Authors:  Aristotelis S Filippidis; M Yashar Kalani; Nicholas Theodore; Harold L Rekate
Journal:  Neurosurg Focus       Date:  2010-07       Impact factor: 4.047

2.  Neurocutaneous melanosis in association with the Dandy-Walker complex.

Authors:  J N Kadonaga; A J Barkovich; M S Edwards; I J Frieden
Journal:  Pediatr Dermatol       Date:  1992-03       Impact factor: 1.588

3.  Coexisting intracranial meningeal melanocytoma, dermoid tumor, and Dandy-Walker cyst in a patient with neurocutaneous melanosis. Case report.

Authors:  Seok-Gu Kang; Do Sung Yoo; Kyoung Suok Cho; Dal Soo Kim; Eon Duck Chang; Pil Woo Huh; Moon Chan Kim
Journal:  J Neurosurg       Date:  2006-03       Impact factor: 5.115

4.  Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis.

Authors:  Vijay Ramaswamy; Holly Delaney; Sofia Haque; Ashfaq Marghoob; Yasmin Khakoo
Journal:  Dev Med Child Neurol       Date:  2012-04-02       Impact factor: 5.449

5.  Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis.

Authors:  F V Bittencourt; A A Marghoob; A W Kopf; K L Koenig; R S Bart
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

6.  Intraspinal melanotic arachnoid cyst and lipoma in neurocutaneous melanosis.

Authors:  V Kasantikul; S Shuangshoti; A Pattanaruenglai; S Kaoroptham
Journal:  Surg Neurol       Date:  1989-02

Review 7.  Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis.

Authors:  Ali Alikhan; Omar A Ibrahimi; Daniel B Eisen
Journal:  J Am Acad Dermatol       Date:  2012-10       Impact factor: 11.527

8.  Tethered cord syndrome and the conus in a normal position.

Authors:  D E Warder; W J Oakes
Journal:  Neurosurgery       Date:  1993-09       Impact factor: 4.654

Review 9.  The borderlands of the primary tethered cord syndrome.

Authors:  W J Oakes
Journal:  Clin Neurosurg       Date:  1996

10.  MR of parenchymal neurocutaneous melanosis.

Authors:  A Demirci; Y Kawamura; G Sze; C Duncan
Journal:  AJNR Am J Neuroradiol       Date:  1995-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.